Serveur d'exploration sur la glutarédoxine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Glutaredoxin 1 (Grx1) Protects Human Retinal Pigment Epithelial Cells From Oxidative Damage by Preventing AKT Glutathionylation.

Identifieur interne : 000551 ( Main/Exploration ); précédent : 000550; suivant : 000552

Glutaredoxin 1 (Grx1) Protects Human Retinal Pigment Epithelial Cells From Oxidative Damage by Preventing AKT Glutathionylation.

Auteurs : Xiaobin Liu [États-Unis] ; Jamieson Jann [États-Unis] ; Christy Xavier [États-Unis] ; Hongli Wu

Source :

RBID : pubmed:25788646

Descripteurs français

English descriptors

Abstract

PURPOSE

Glutaredoxin 1 (Grx1) belongs to the oxidoreductase family and is a component of the endogenous antioxidant defense system. However, its physiological function remains largely unknown. In this study, we investigated whether and how Grx1 overexpression protects the retinal pigment epithelial (RPE) cells against H2O2-induced apoptosis.

METHODS

Human retinal pigment epithelial (ARPE-19) cells were transfected with either a Grx1-containing plasmid or an empty vector. Primary human RPE cells were transfected with Grx1 small interfering RNA (siRNA) or scrambled siRNA. Cell viability was measured with the WST8 assay. Apoptosis was quantitatively measured by annexin V/propidium iodide (PI) double staining. The level of protein glutathionylation (PSSG) was measured by immunoblotting using anti-PSSG antibody. Protein kinase B (AKT) activation was examined by Western blot. Protein kinase B glutathionylation was detected by immunoprecipitation followed by immunoblotting with anti-PSSG antibody.

RESULTS

Glutaredoxin 1 overexpression protected ARPE-19 cells from H2O2-induced cell viability loss. Conversely, Grx1 gene knockdown sensitized primary human RPE cells to H2O2. Assessment of apoptosis indicated that cells transfected with the Grx1-containing plasmid were more resistant to H2O2 with fewer cells undergoing apoptosis as compared to empty vector-transfected cells. Hydrogen peroxide-induced PSSG accumulation was also attenuated by Grx1 enrichment. Furthermore, Grx1 overexpression prevented H2O2-induced AKT glutathionylation, resulting in a sustained phospho-AKT elevation in RPE cells.

CONCLUSIONS

Glutaredoxin 1 can protect RPE cells against oxidative stress-induced apoptosis. The mechanism of this protection is associated with its ability to stimulate the phosphorylation of AKT by preventing AKT glutathionylation. Considering Grx1's protective abilities in RPE cells, Grx1 could be a potential pharmacological target for retinal degenerative diseases.


DOI: 10.1167/iovs.14-15876
PubMed: 25788646


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Glutaredoxin 1 (Grx1) Protects Human Retinal Pigment Epithelial Cells From Oxidative Damage by Preventing AKT Glutathionylation.</title>
<author>
<name sortKey="Liu, Xiaobin" sort="Liu, Xiaobin" uniqKey="Liu X" first="Xiaobin" last="Liu">Xiaobin Liu</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jann, Jamieson" sort="Jann, Jamieson" uniqKey="Jann J" first="Jamieson" last="Jann">Jamieson Jann</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Xavier, Christy" sort="Xavier, Christy" uniqKey="Xavier C" first="Christy" last="Xavier">Christy Xavier</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wu, Hongli" sort="Wu, Hongli" uniqKey="Wu H" first="Hongli" last="Wu">Hongli Wu</name>
<affiliation>
<nlm:affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States 2North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Wort.</nlm:affiliation>
<wicri:noCountry code="subField">Fort Wort</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25788646</idno>
<idno type="pmid">25788646</idno>
<idno type="doi">10.1167/iovs.14-15876</idno>
<idno type="wicri:Area/Main/Corpus">000548</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000548</idno>
<idno type="wicri:Area/Main/Curation">000548</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000548</idno>
<idno type="wicri:Area/Main/Exploration">000548</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Glutaredoxin 1 (Grx1) Protects Human Retinal Pigment Epithelial Cells From Oxidative Damage by Preventing AKT Glutathionylation.</title>
<author>
<name sortKey="Liu, Xiaobin" sort="Liu, Xiaobin" uniqKey="Liu X" first="Xiaobin" last="Liu">Xiaobin Liu</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jann, Jamieson" sort="Jann, Jamieson" uniqKey="Jann J" first="Jamieson" last="Jann">Jamieson Jann</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Xavier, Christy" sort="Xavier, Christy" uniqKey="Xavier C" first="Christy" last="Xavier">Christy Xavier</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wu, Hongli" sort="Wu, Hongli" uniqKey="Wu H" first="Hongli" last="Wu">Hongli Wu</name>
<affiliation>
<nlm:affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States 2North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Wort.</nlm:affiliation>
<wicri:noCountry code="subField">Fort Wort</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Investigative ophthalmology & visual science</title>
<idno type="eISSN">1552-5783</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Apoptosis (drug effects)</term>
<term>Apoptosis (physiology)</term>
<term>Cell Survival (drug effects)</term>
<term>Cells, Cultured (MeSH)</term>
<term>Cytoprotection (physiology)</term>
<term>Gene Knockdown Techniques (MeSH)</term>
<term>Glutaredoxins (biosynthesis)</term>
<term>Glutaredoxins (genetics)</term>
<term>Glutaredoxins (physiology)</term>
<term>Glutathione (metabolism)</term>
<term>Glutathione Disulfide (metabolism)</term>
<term>Humans (MeSH)</term>
<term>Hydrogen Peroxide (pharmacology)</term>
<term>Membrane Transport Proteins (metabolism)</term>
<term>Oxidation-Reduction (MeSH)</term>
<term>Oxidative Stress (physiology)</term>
<term>Proto-Oncogene Proteins c-akt (metabolism)</term>
<term>Proto-Oncogene Proteins c-akt (physiology)</term>
<term>Proto-Oncogene Proteins c-bcl-2 (biosynthesis)</term>
<term>Retinal Pigment Epithelium (cytology)</term>
<term>Retinal Pigment Epithelium (drug effects)</term>
<term>Retinal Pigment Epithelium (metabolism)</term>
<term>bcl-2-Associated X Protein (biosynthesis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Apoptose (effets des médicaments et des substances chimiques)</term>
<term>Apoptose (physiologie)</term>
<term>Cellules cultivées (MeSH)</term>
<term>Cytoprotection (physiologie)</term>
<term>Disulfure de glutathion (métabolisme)</term>
<term>Glutarédoxines (biosynthèse)</term>
<term>Glutarédoxines (génétique)</term>
<term>Glutarédoxines (physiologie)</term>
<term>Glutathion (métabolisme)</term>
<term>Humains (MeSH)</term>
<term>Oxydoréduction (MeSH)</term>
<term>Peroxyde d'hydrogène (pharmacologie)</term>
<term>Protéine Bax (biosynthèse)</term>
<term>Protéines de transport membranaire (métabolisme)</term>
<term>Protéines proto-oncogènes c-akt (métabolisme)</term>
<term>Protéines proto-oncogènes c-akt (physiologie)</term>
<term>Protéines proto-oncogènes c-bcl-2 (biosynthèse)</term>
<term>Stress oxydatif (physiologie)</term>
<term>Survie cellulaire (effets des médicaments et des substances chimiques)</term>
<term>Techniques de knock-down de gènes (MeSH)</term>
<term>Épithélium pigmentaire de la rétine (cytologie)</term>
<term>Épithélium pigmentaire de la rétine (effets des médicaments et des substances chimiques)</term>
<term>Épithélium pigmentaire de la rétine (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Glutaredoxins</term>
<term>Proto-Oncogene Proteins c-bcl-2</term>
<term>bcl-2-Associated X Protein</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Glutarédoxines</term>
<term>Protéine Bax</term>
<term>Protéines proto-oncogènes c-bcl-2</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Épithélium pigmentaire de la rétine</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Retinal Pigment Epithelium</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Apoptosis</term>
<term>Cell Survival</term>
<term>Retinal Pigment Epithelium</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Apoptose</term>
<term>Survie cellulaire</term>
<term>Épithélium pigmentaire de la rétine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Glutaredoxins</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Glutarédoxines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Glutathione</term>
<term>Glutathione Disulfide</term>
<term>Membrane Transport Proteins</term>
<term>Proto-Oncogene Proteins c-akt</term>
<term>Retinal Pigment Epithelium</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Disulfure de glutathion</term>
<term>Glutathion</term>
<term>Protéines de transport membranaire</term>
<term>Protéines proto-oncogènes c-akt</term>
<term>Épithélium pigmentaire de la rétine</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Peroxyde d'hydrogène</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Hydrogen Peroxide</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Apoptose</term>
<term>Cytoprotection</term>
<term>Glutarédoxines</term>
<term>Protéines proto-oncogènes c-akt</term>
<term>Stress oxydatif</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Apoptosis</term>
<term>Cytoprotection</term>
<term>Glutaredoxins</term>
<term>Oxidative Stress</term>
<term>Proto-Oncogene Proteins c-akt</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cells, Cultured</term>
<term>Gene Knockdown Techniques</term>
<term>Humans</term>
<term>Oxidation-Reduction</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cellules cultivées</term>
<term>Humains</term>
<term>Oxydoréduction</term>
<term>Techniques de knock-down de gènes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>PURPOSE</b>
</p>
<p>Glutaredoxin 1 (Grx1) belongs to the oxidoreductase family and is a component of the endogenous antioxidant defense system. However, its physiological function remains largely unknown. In this study, we investigated whether and how Grx1 overexpression protects the retinal pigment epithelial (RPE) cells against H2O2-induced apoptosis.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>Human retinal pigment epithelial (ARPE-19) cells were transfected with either a Grx1-containing plasmid or an empty vector. Primary human RPE cells were transfected with Grx1 small interfering RNA (siRNA) or scrambled siRNA. Cell viability was measured with the WST8 assay. Apoptosis was quantitatively measured by annexin V/propidium iodide (PI) double staining. The level of protein glutathionylation (PSSG) was measured by immunoblotting using anti-PSSG antibody. Protein kinase B (AKT) activation was examined by Western blot. Protein kinase B glutathionylation was detected by immunoprecipitation followed by immunoblotting with anti-PSSG antibody.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Glutaredoxin 1 overexpression protected ARPE-19 cells from H2O2-induced cell viability loss. Conversely, Grx1 gene knockdown sensitized primary human RPE cells to H2O2. Assessment of apoptosis indicated that cells transfected with the Grx1-containing plasmid were more resistant to H2O2 with fewer cells undergoing apoptosis as compared to empty vector-transfected cells. Hydrogen peroxide-induced PSSG accumulation was also attenuated by Grx1 enrichment. Furthermore, Grx1 overexpression prevented H2O2-induced AKT glutathionylation, resulting in a sustained phospho-AKT elevation in RPE cells.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSIONS</b>
</p>
<p>Glutaredoxin 1 can protect RPE cells against oxidative stress-induced apoptosis. The mechanism of this protection is associated with its ability to stimulate the phosphorylation of AKT by preventing AKT glutathionylation. Considering Grx1's protective abilities in RPE cells, Grx1 could be a potential pharmacological target for retinal degenerative diseases.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">25788646</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>09</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>06</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1552-5783</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2015</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Investigative ophthalmology & visual science</Title>
<ISOAbbreviation>Invest Ophthalmol Vis Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Glutaredoxin 1 (Grx1) Protects Human Retinal Pigment Epithelial Cells From Oxidative Damage by Preventing AKT Glutathionylation.</ArticleTitle>
<Pagination>
<MedlinePgn>2821-32</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1167/iovs.14-15876</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Glutaredoxin 1 (Grx1) belongs to the oxidoreductase family and is a component of the endogenous antioxidant defense system. However, its physiological function remains largely unknown. In this study, we investigated whether and how Grx1 overexpression protects the retinal pigment epithelial (RPE) cells against H2O2-induced apoptosis.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Human retinal pigment epithelial (ARPE-19) cells were transfected with either a Grx1-containing plasmid or an empty vector. Primary human RPE cells were transfected with Grx1 small interfering RNA (siRNA) or scrambled siRNA. Cell viability was measured with the WST8 assay. Apoptosis was quantitatively measured by annexin V/propidium iodide (PI) double staining. The level of protein glutathionylation (PSSG) was measured by immunoblotting using anti-PSSG antibody. Protein kinase B (AKT) activation was examined by Western blot. Protein kinase B glutathionylation was detected by immunoprecipitation followed by immunoblotting with anti-PSSG antibody.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Glutaredoxin 1 overexpression protected ARPE-19 cells from H2O2-induced cell viability loss. Conversely, Grx1 gene knockdown sensitized primary human RPE cells to H2O2. Assessment of apoptosis indicated that cells transfected with the Grx1-containing plasmid were more resistant to H2O2 with fewer cells undergoing apoptosis as compared to empty vector-transfected cells. Hydrogen peroxide-induced PSSG accumulation was also attenuated by Grx1 enrichment. Furthermore, Grx1 overexpression prevented H2O2-induced AKT glutathionylation, resulting in a sustained phospho-AKT elevation in RPE cells.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Glutaredoxin 1 can protect RPE cells against oxidative stress-induced apoptosis. The mechanism of this protection is associated with its ability to stimulate the phosphorylation of AKT by preventing AKT glutathionylation. Considering Grx1's protective abilities in RPE cells, Grx1 could be a potential pharmacological target for retinal degenerative diseases.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Xiaobin</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jann</LastName>
<ForeName>Jamieson</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xavier</LastName>
<ForeName>Christy</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Hongli</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Pharmaceutical Sciences University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States 2North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Wort.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Invest Ophthalmol Vis Sci</MedlineTA>
<NlmUniqueID>7703701</NlmUniqueID>
<ISSNLinking>0146-0404</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C494826">BAX protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C516005">GLRX protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019253">Proto-Oncogene Proteins c-bcl-2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051028">bcl-2-Associated X Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C086860">glutathione transporter</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>BBX060AN9V</RegistryNumber>
<NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>GAN16C9B8O</RegistryNumber>
<NameOfSubstance UI="D005978">Glutathione</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>ULW86O013H</RegistryNumber>
<NameOfSubstance UI="D019803">Glutathione Disulfide</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019610" MajorTopicYN="N">Cytoprotection</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019803" MajorTopicYN="N">Glutathione Disulfide</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019253" MajorTopicYN="N">Proto-Oncogene Proteins c-bcl-2</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055213" MajorTopicYN="N">Retinal Pigment Epithelium</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051028" MajorTopicYN="N">bcl-2-Associated X Protein</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>3</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>3</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>9</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25788646</ArticleId>
<ArticleId IdType="pii">iovs.14-15876</ArticleId>
<ArticleId IdType="doi">10.1167/iovs.14-15876</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Wu, Hongli" sort="Wu, Hongli" uniqKey="Wu H" first="Hongli" last="Wu">Hongli Wu</name>
</noCountry>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Liu, Xiaobin" sort="Liu, Xiaobin" uniqKey="Liu X" first="Xiaobin" last="Liu">Xiaobin Liu</name>
</region>
<name sortKey="Jann, Jamieson" sort="Jann, Jamieson" uniqKey="Jann J" first="Jamieson" last="Jann">Jamieson Jann</name>
<name sortKey="Xavier, Christy" sort="Xavier, Christy" uniqKey="Xavier C" first="Christy" last="Xavier">Christy Xavier</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000551 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000551 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25788646
   |texte=   Glutaredoxin 1 (Grx1) Protects Human Retinal Pigment Epithelial Cells From Oxidative Damage by Preventing AKT Glutathionylation.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25788646" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GlutaredoxinV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020